| Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study P Kumar, T Bhardwaj, A Kumar, BR Gehi, SK Kapuganti, N Garg, G Nath, ... Journal of Biomolecular Structure and Dynamics 40 (7), 3170-3184, 2022 | 30 | 2022 |
| Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach A Kumar, P Kumar, KU Saumya, SK Kapuganti, T Bhardwaj, R Giri Expert review of vaccines 19 (9), 887-898, 2020 | 30 | 2020 |
| Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes T Bhardwaj, K Gadhave, SK Kapuganti, P Kumar, ZF Brotzakis, ... Nature Communications 14 (1), 945, 2023 | 23 | 2023 |
| Unstructured biology of proteins from ubiquitin-proteasome system: roles in cancer and neurodegenerative diseases K Gadhave, P Kumar, SK Kapuganti, VN Uversky, R Giri Biomolecules 10 (5), 796, 2020 | 23 | 2020 |
| Translation-associated mutational U-pressure in the first ORF of SARS-CoV-2 and other coronaviruses VV Khrustalev, R Giri, TA Khrustaleva, SK Kapuganti, AN Stojarov, ... Frontiers in Microbiology 11, 559165, 2020 | 20 | 2020 |
| Naturally occurring bioactives as antivirals: emphasis on coronavirus infection SA Ayatollahi, J Sharifi-Rad, PV Tsouh Fokou, GB Mahady, ... Frontiers in pharmacology 12, 575877, 2021 | 16 | 2021 |
| Environmental dependence of the structure of the c-terminal domain of the SARS-CoV-2 envelope protein K Gadhave, A Kumar, P Kumar, SK Kapuganti, N Garg, M Vendruscolo, ... bioRxiv, 2020.12. 29.424646, 2020 | 5 | 2020 |
| Structural dynamics of Zika virus NS1 via a reductionist approach reveal the disordered nature of its β-roll domain in isolation SK Kapuganti, P Kumar, R Giri Virology 573, 72-83, 2022 | 4 | 2022 |
| Role of structural disorder in the multi-functionality of flavivirus proteins SK Kapuganti, A Bhardwaj, P Kumar, T Bhardwaj, N Nayak, VN Uversky, ... Expert Review of Proteomics 19 (3), 183-196, 2022 | 3 | 2022 |
| Vaccine Omics: role of bioinformatics in vaccinology SK Kapuganti, A Bhardwaj, N Nayak, T Bhardwaj, P Kumar, R Giri System Vaccinology, 33-54, 2022 | 3 | 2022 |
| Investigating the aggregation perspective of Dengue virus proteome SK Kapuganti, KU Saumya, D Verma, R Giri Virology 586, 12-22, 2023 | 1 | 2023 |
| p53 TAD2 Domain (38–61) Forms Amyloid-like Aggregates in Isolation K Gadhave, SK Kapuganti, PM Mishra, R Giri ACS Chemical Neuroscience 13 (15), 2281-2287, 2022 | 1 | 2022 |
| The aggregation potential of Zika virus proteome R Giri, T Bhardwaj, KU Saumya, K Gadhave, SK Kapuganti, N Sharma bioRxiv, 2022.03. 26.485915, 2022 | 1 | 2022 |
| Widespread amyloid aggregates formation by Zika virus proteins and peptides R Giri, T Bhardwaj, SK Kapuganti, KU Saumya, N Sharma, A Bhardwaj, ... Protein Science 32 (12), e4833, 2023 | | 2023 |
| Coronavirus Epidemics and the Current COVID-19 Pandemic A Bhardwaj, P Kumar, SK Kapuganti, VN Uversky, R Giri COVID-19, 1-18, 2022 | | 2022 |
